Woodcock doubtful of proposed FDA foreign inspection rules

05/1/2008 | Wall Street Journal, The

FDA drug unit director Janet Woodcock on Thursday rejected calls by Democratic lawmakers to back legislation that would tighten rules on product imports, expressing concern with parts of the bill that would require the agency to inspect overseas manufacturers every two years. Woodcock, who said the inspection requirement might be a financial burden to the FDA, was also reluctant to impose registration user fees for drug and device makers.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC
Associate Director, Compliance & Ethics, US Operations Ops II
Bristol-Myers Squibb
Plainsboro, NJ
Senior Associate, Health Economics - Heart Valve Therapy
Edwards Lifesciences
Irvine, CA